Osteogenesis Imperfecta - Brittle Bone Intro

- Definition: Inherited connective tissue disorder characterized by fragile bones that fracture easily.
- Aka: Brittle Bone Disease.
- Genetic Basis: Primarily a defect in Type I collagen synthesis.
- Most commonly due to mutations in COL1A1 or COL1A2 genes.
- Inheritance: Predominantly Autosomal Dominant (AD); some rare forms are Autosomal Recessive (AR).
- Pathophysiology: Leads to either:
- Quantitative defect: ↓ production of structurally normal Type I collagen (milder forms).
- Qualitative defect: Production of abnormal Type I collagen (more severe forms).
⭐ OI is the most common inherited bone fragility disorder, affecting approximately 1 in 10,000 to 20,000 births worldwide.
Osteogenesis Imperfecta - Shattered Showcase
- Patho: Type I collagen defect (COL1A1/A2 genes). "Brittle Bone Disease".
- Key Features (📌 "BITE"):
- Bones: Multiple fractures, osteopenia, short stature, bone deformities.
- I (Eyes): Blue sclerae.
- Teeth: Dentinogenesis imperfecta (opalescent, discolored).
- Ear: Hearing loss (conductive/mixed).
- Also: Wormian bones (skull), joint laxity, basilar invagination, easy bruising.
- Sillence Classification (Main Types):
- Type I: Mildest, persistent blue sclerae. AD.
- Type II: Most severe, lethal perinatal. AR/New Mutation.
- Type III: Progressive deforming, variable sclerae. AD/AR.
- Type IV: Intermediate, normal/grey sclerae. AD.
- Dx: Clinical; genetic tests (COL1A1/A2). X-ray: osteopenia, fractures, deformities.
- Rx: Bisphosphonates (IV pamidronate), supportive (PT, OT, surgery).
⭐ Blue sclerae are a hallmark sign, caused by the thinness of the sclera allowing the underlying choroidal pigment to show through.
Osteogenesis Imperfecta - Cracking the Code
- Genetic disorder: Defective type I collagen (COL1A1/COL1A2 genes) → "brittle bone disease".
- Key features: Multiple fractures, blue sclera, hearing loss, dentinogenesis imperfecta (DI), short stature, joint laxity.
Sillence Classification (Simplified)
| Type | Inheritance | Severity | Sclera | Fractures | DI | Other Key Features |
|---|---|---|---|---|---|---|
| I | AD | Mild | Blue | Post-natal, ↓ age | Rare | Most common, hearing loss (50%) |
| II | AD/AR | Perinatal Lethal | Dark Blue | In utero/birth, severe | Variable | Beaded ribs, crumpled femurs |
| III | AD/AR | Prog. Deforming | Blue/Normal | At birth, severe | Common | Very short, triangular facies |
| IV | AD | Moderate | Normal | Variable, bone bowing | Common | Basilar invagination |
- Management: Bisphosphonates (e.g., Pamidronate), fracture care, physiotherapy, surgical correction.
⭐ Wormian bones (sutural bones) are a characteristic X-ray finding in Osteogenesis Imperfecta.
Osteogenesis Imperfecta - Mending the Matrix
- Genetic disorder: Defective type I collagen (COL1A1/A2 genes). "Brittle bone disease".
- Clinical (📌 OI-FEATURES):
- Multiple fractures, minimal trauma.
- Blue sclerae (thin, visible choroid).
- Hearing loss (conductive/mixed).
- Dentinogenesis imperfecta (opalescent teeth).
- Short stature, scoliosis, wormian bones.
- Sillence Types:
- I: Mild, blue sclerae.
- II: Perinatal lethal (most severe).
- III: Progressive deforming.
- IV: Moderate, normal sclerae.
- Radiology: Osteopenia, thin cortices, bowing, "codfish" vertebrae, popcorn epiphyses.

- Management: Multidisciplinary.
- Medical: Bisphosphonates (pamidronate) ↓ fractures, ↑ bone density.
- Surgical: Intramedullary rodding (Fassier-Duval rods).
- Supportive: Physio, dental, hearing aids.
⭐ Type II OI is the most severe form, often leading to perinatal lethality due to severe skeletal fragility and respiratory complications.
High‑Yield Points - ⚡ Biggest Takeaways
- Primarily a Type I collagen synthesis defect (COL1A1/COL1A2 genes).
- Classic triad: blue sclerae, recurrent fractures with minimal trauma, and hearing loss.
- Dentinogenesis imperfecta (opalescent teeth) is a frequent finding.
- Sillence classification: Type I (mildest, most common), Type II (most severe, lethal in perinatal period).
- Wormian bones on skull X-ray and generalized osteopenia are characteristic.
- Management focuses on bisphosphonates, fracture prevention, and surgical correction of deformities.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app
